Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosusSVENUNGSSON, Elisabet; GUNNARSSON, Iva; FEI, Guo-Zhong et al.Arthritis and rheumatism. 2003, Vol 48, Num 9, pp 2533-2540, issn 0004-3591, 8 p.Article

Longitudinal study of interleukin-10, tumor necrosis factor-α, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue diseaseHASSAN, Adla B; GUNNARSSON, Iva; KARLSSON, Göran et al.Scandinavian journal of rheumatology. 2001, Vol 30, Num 5, pp 282-289, issn 0300-9742Article

Longitudinal study of interleukin-10, tumor necrosis factor-α, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue diseaseHASSAN, Adla B; GUNNARSSON, Iva; KARLSSON, Göran et al.Scandinavian journal of rheumatology. 2001, Vol 30, Num 5, pp 282-289, issn 0300-9742Article

Women's experience of SLE-related fatigue: a focus group interview studyPETTERSSON, Susanne; MÖLLER, Sonia; SVENUNGSSON, Elisabet et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 10, pp 1935-1942, issn 1462-0324, 8 p.Article

Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathyLUNDBERG, Sigrid; LUNDAHL, Joachim; GUNNARSSON, Iva et al.Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 5, pp 1916-1923, issn 0931-0509, 8 p.Article

Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense depositsJONSDOTTIR, Thorunn; SUNDELIN, Birgitta; WELIN HENRIKSSON, Elisabet et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 1172-1173, issn 0003-4967, 2 p.Article

Lower Expression Levels of the Programmed Death 1 Receptor on CD4+CD25+ T Cells and Correlation With the PD-1.3A Genotype in Patients With Systemic Lupus ErythematosusKRISTJANSDOTTIR, Helga; STEINSSON, Kristjan; GUNNARSSON, Iva et al.Arthritis and rheumatism. 2010, Vol 62, Num 6, pp 1702-1711, issn 0004-3591, 10 p.Article

A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosusSVENUNGSSON, Elisabet; GUSTAFSSON, Johanna; ELVIN, Kerstin et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 5, pp 834-840, issn 0003-4967, 7 p.Article

Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosusKOZYREV, Sergey V; ABELSON, Anna-Karin; TRUEDSSON, Lennart et al.Nature genetics. 2008, Vol 40, Num 2, pp 211-216, issn 1061-4036, 6 p.Article

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLEVALLERSKOG, Therese; GUNNARSSON, Iva; WIDHE, Mona et al.Clinical immunology (Orlando, Fla. Print). 2007, Vol 122, Num 1, pp 62-74, issn 1521-6616, 13 p.Article

A large-scale replication study identifies TIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusGATEVA, Vesela; SANDLING, Johanna K; GUNNARSSON, Iva et al.Nature genetics. 2009, Vol 41, Num 11, pp 1228-1233, issn 1061-4036, 6 p.Article

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestationsFROSTEGARD, Johan; SVENUNGSSON, Elisabet; RUIHUA WU et al.Arthritis and rheumatism. 2005, Vol 52, Num 1, pp 192-200, issn 0004-3591, 9 p.Article

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humansPROKUNINA, Ludmila; CASTILLEJO-LOPEZ, Casimiro; BOLSTAD, Anne Isine et al.Nature genetics. 2002, Vol 32, Num 4, pp 666-669, issn 1061-4036, 4 p.Article

Genetically Distinct Subsets within ANCA-Associated VasculitisLYONS, Paul A; RAYNER, Tim F; COHEN TERVAERT, Jan Willem et al.The New England journal of medicine. 2012, Vol 367, Num 3, pp 214-223, issn 0028-4793, 10 p.Article

A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLESANDLING, Johanna K; GAMIER, Sophie; BENGTSSON, Anders A et al.European journal of human genetics. 2011, Vol 19, Num 4, pp 479-484, issn 1018-4813, 6 p.Article

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathyVUONG, Mai T; HAHN-ZORIC, Mirjana; JACOBSON, Stefan H et al.Kidney international. 2010, Vol 78, Num 12, pp 1281-1287, issn 0085-2538, 7 p.Article

Association of Systemic Lupus Erythematosus with C8orf13-BLK and ITGAM-ITGAXHOM, Geoffrey; GRAHAM, Robert R; BALLINGER, Dennis G et al.The New England journal of medicine. 2008, Vol 358, Num 9, pp 900-909, issn 0028-4793, 10 p.Article

Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosusSANCHEZ, Elena; ABELSON, Anna-Karin; SVENUNGSSON, Elisabet et al.Arthritis and rheumatism. 2007, Vol 56, Num 9, pp 3080-3086, issn 0004-3591, 7 p.Article

Dual Effect of the Macrophage Migration Inhibitory Factor Gene on the Development and Severity of Human Systemic Lupus ErythematosusSREIH, Antoine; EZZEDDINE, Rana; SVENUNGSSON, Elisabet et al.Arthritis and rheumatism. 2011, Vol 63, Num 12, pp 3942-3951, issn 0004-3591, 10 p.Article

Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathyMAI TUYET VUONG; LUNDBERG, Sigrid; PADYUKOV, Leonid et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 10, pp 3061-3067, issn 0931-0509, 7 p.Article

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5SIGURDSSON, Snaevar; NORDMARK, Gunnel; BENGTSSON, Anders A et al.Human molecular genetics (Print). 2008, Vol 17, Num 18, pp 2868-2876, issn 0964-6906, 9 p.Article

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritisGUNNARSSON, Iva; SUNDELIN, Birgitta; JONSDOTTIR, Thorunn et al.Arthritis and rheumatism. 2007, Vol 56, Num 4, pp 1263-1272, issn 0004-3591, 10 p.Article

The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritisPROKUNINA, Ludmila; GUNNARSSON, Iva; STURFELT, Gunnar et al.Arthritis and rheumatism. 2004, Vol 50, Num 1, pp 327-328, issn 0004-3591, 2 p.Article

Repeated renal biopsy in proliferative lupus nephritis: Predictive role of serum c1q and albuminuriaGUNNARSSON, Iva; SUNDELIN, Birgitta; HEIMBÜRGER, Mikael et al.Journal of rheumatology. 2002, Vol 29, Num 4, pp 693-699, issn 0315-162XArticle

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohortsJONSDOTTIR, Thórunn; GUNNARSSON, Iva; MOURAO, Ana Filipa et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 8, pp 1502-1504, issn 1462-0324, 3 p.Article